Cisplatin-based combined modality therapy for anal carcinoma: A wider therapeutic index

Cancer

Volumn 97, Issue 5, 2003, Pages 1195-1202

  Hung, Arthur ^a   Crane, Christopher ^a   Delclos, Marc ^a   Ballo, Matthew ^a   Ajani, Jaffer ^a   Lin, Edward ^a   Feig, Barry ^a   Skibber, John ^a   Janjan, Nora ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Anal carcinoma; Chemoradiation; Cisplatin; Combined therapy

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; ANUS CARCINOMA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLOSTOMY; DEHYDRATION; DESQUAMATION; DIARRHEA; DRUG TOLERABILITY; FEMALE; FISTULA; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RADIATION NECROSIS; RETROSPECTIVE STUDY; SKIN ULCER; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; PILOT PROJECTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037369169     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11161     Document Type: Article

References (26)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA. 2000;50:7-33.
2. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17:354-356.
3. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040-2049.
4. Anonymous. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet. 1996;348:1049-1054.
5. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996; 14:2527-2539.
6. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer [see comments]. N Engl J Med. 1999;340:1137-1143.
7. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer [see comments]. [Erratum appears in N Engl J Med 1999 Aug 26;341(9):7081. N Engl J Med. 1999;340:1144-1153.
8. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma [see comments]. [Erratum appears in N Engl J Med 1999 Aug 26;341(9):7081. N Engl J Med. 1999;340:1154-1161.
9. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 1994;331:502-507.
10. Rich TA, Ajani JA, Morrison WH, et al. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol. 1993;27:209-215.
11. Mak AC, Rich TA, Schultheiss TE, et al. Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys. 1994;28:597-603.
12. John M. Five year results and analyses of a phase III randomized RTOG/ECOG chemoradiation protocol for anal cancer [abstract]. Proc Am Soc Clin Oncol. 1998;17:258a.
13. Mitchell SE, Mendenhall WM, Zlotecki RA, et al. Squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2001;49:1007-13.
14. Martenson JA, Lipsitz SR, Wagner H Jr., et al. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys. 1996;35:745-749.
15. Pintor MP, Northover JM, Nicholls RJ. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg. 1989;76:806-810.
16. Allal AS, Sprangers MA, Laurencet F, et al. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer. 1999;80:1588-1594.
17. Fyles A, Keane TJ, Barton M, et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 1992;25:273-279.
18. Lanciano RM, Pajak TF, Martz K, et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys. 1993;25:391-397.
19. Taylor JM, Withers HR, Mendenhall WM. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol. 1990;17:95-102.
20. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131-146.
21. Callister M, Janjan N, Brown T, et al. Effective management of treatment-related enteritis during preoperative chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2000;48:225-226.
22. Place RJ, Gregorcyk SG, Huber PJ, et al. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum. 2001;44:506-512.
23. Palefsky JM. Human papillomavirus-related tumors. AIDS. 2000;14:S189-S195.
24. Weber DC, Kurtz JM, Allal AS. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys. 2001;50:675-680.
25. Hu K, Minsky BD, Cohen AM, et al. 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol. 1999;70:71-77.
26. RTOG: RTOG 98-11: a phase III randomized study of 5-fluorouracil, mitomycin-C, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. 1998:1-52.